4.7 Editorial Material

Caught in the antiviral crossfire Ganciclovir-associated mutagenesis in HSC transplant recipients

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Somatic mutation landscapes at single-molecule resolution

Federico Abascal et al.

Summary: The study developed a method to detect mutations in single cells or small clones, revealing that somatic mutations also occur in non-dividing cells and contribute significantly to somatic mutagenesis.

NATURE (2021)

Article Multidisciplinary Sciences

Lineage tracing of human development through somatic mutations

Michael Spencer Chapman et al.

Summary: By reconstructing a phylogenetic tree of blood development in healthy human fetuses, it was found that individual haematopoietic progenitors acquire multiple somatic mutations by 18 weeks after conception. The data also support a hypoblast origin of the extra-embryonic mesoderm and primitive blood in humans.

NATURE (2021)

Article Cell & Tissue Engineering

Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients

Jurrian K. de Kanter et al.

Summary: The majority of transplanted HSPCs did not show altered mutation accumulation post-transplantation, but in some recipients, multiple HSPCs exhibited an increased mutation burden. This increase was attributed to a unique mutational signature caused by antiviral drug ganciclovir, which may contribute to therapy-related carcinogenesis in transplant recipients.

CELL STEM CELL (2021)

Article Multidisciplinary Sciences

The repertoire of mutational signatures in human cancer

Ludmil B. Alexandrov et al.

NATURE (2020)

Article Medicine, General & Internal

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

F. M. Marty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Hematology

The replication rate of human hematopoietic stem cells in vivo

Sandra N. Catlin et al.

BLOOD (2011)